Cardiovascular Therapeutics

Cover image for Vol. 33 Issue 4

Edited By: Henry Krum, PhD and Chim C. Lang, MD,

Impact Factor: 2.362

ISI Journal Citation Reports © Ranking: 2014: 57/123 (Cardiac & Cardiovascular Systems); 128/254 (Pharmacology & Pharmacy)

Online ISSN: 1755-5922

Recently Published Issues

See all

Online CDR Content

Accepted Articles(accepted manuscripts)

Accepted Articles have been accepted for publication in CDR, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.

Early View(e-pub ahead of print)

CDR's Early View articles are definitive in format and presented in advance of print publication.

EXPEDITED: publish your clinical trials faster

further information

EXPEDITED is the new priority publication service from Cardiovascular Therapeutics exclusively for well conducted, well reported clinical trials.

  • Priority peer review: 7 working days from online submission.
  • Priority proofs: 7 working days from 'accept' decision.
  • Priority online: 7 working days from proof approval to Early View publication.

Click here for more information.

Why you should submit your next paper to Cardiovascular Therapeutics

Submit today

* Rapid online publication upon article acceptance, with EXPEDITED publication for clinical trials
* Impact Factor: 2.362 (2015 Journal Citation Reports® Science Edition [Thomson Reuters, 2015])
* Read and cited across the world - over 100,000 full text articles downloaded in 2014
* Option to pay to make the full text of your article universally accessible immediately upon publication, using OnlineOpen Open Access
* Easy online manuscript submission on ScholarOne
* Altmetric article scores allow you to measure the online impact of your research
* Publishes articles in cardiovascular pharmacology and clinical pharmacology, and clinical trials of new or potential cardiovascular therapies  

Join your peers and submit your work to Cardiovascular Therapeutics at http://mc.manuscriptcentral.com/cdr

SEARCH

SEARCH BY CITATION